Data Collection only. By reviewing the charts of CAH infants who come to our facility for treatment, we hope to discover which treatments, all of which are standard of care, lead to better outcomes for patients (primarily in the first year of life).
This research is being done to test the safety and effectiveness of intranasal carbetocin to treat Prader Willi Syndrome.
To explore the safety and treatment effect of intravenous (IV) Remodulin as add on therapy in neonates with PPHN compared to placebo.
Study early development in infants who have an older sibling with autism.
To find out the effects of a chemical in Stevia on the symptoms of NAFLD.
To better understand the effects of nutrition in early pregnancy on infant growth and development.
To evaluate the efficacy of tofacitinib based on remission in pediatric participants with moderately to severely active Ulcerative Colitis (UC).
The primary aim of this registry will be to identify genes and/or biologic and environmental factors that either cause these tumors or increase one's risk for developing them. Ultimately, research using this registry may result in improved diagnosis, more effective treatments and possibly prevention.
